U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Upalsecovatein
INN  
Official Name English
Viral spike glycoprotein NVX-CoV2540 [664-glutamine,665-glutamine,667-glutamine,968-proline,969-proline] (severe acute respiratory syndrome coronavirus 2 variant B.1.1.529.5)
Preferred Name English
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron lineage B.1.1.529.5 also known as BA.5 (GISAID: EPI_ISL_12097410) spike (S) glycoprotein (S glycoprotein) (1-1255), stable prefusion conformation variant (R<sup>664</sup>>Q, R<sup>665</
Common Name English
upalsecovatein [INN]
Common Name English
Code System Code Type Description
CAS
2918783-99-8
Created by admin on Wed Apr 02 18:34:04 GMT 2025 , Edited by admin on Wed Apr 02 18:34:04 GMT 2025
PRIMARY
FDA UNII
RBJ7D8ZH4X
Created by admin on Wed Apr 02 18:34:04 GMT 2025 , Edited by admin on Wed Apr 02 18:34:04 GMT 2025
PRIMARY
SMS_ID
300000050475
Created by admin on Wed Apr 02 18:34:04 GMT 2025 , Edited by admin on Wed Apr 02 18:34:04 GMT 2025
PRIMARY
NCI_THESAURUS
C203085
Created by admin on Wed Apr 02 18:34:04 GMT 2025 , Edited by admin on Wed Apr 02 18:34:04 GMT 2025
PRIMARY
INN
13093
Created by admin on Wed Apr 02 18:34:04 GMT 2025 , Edited by admin on Wed Apr 02 18:34:04 GMT 2025
PRIMARY
ACTIVE MOIETY
Upalsecovatein
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966